Intracellular Determination of Activated Caspases (IDAC) by Flow Cytometry Using a Pancaspase Inhibitor Labeled with FITC

Cytometry Part A

Volumn 56, Issue 2, 2003, Pages 104-112

  Jayaraman, Sundararajan ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Intracellular detection of activated caspases; Pancaspase inhibitor linked to fluorescein isothiocyanate

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE; CASPASE INHIBITOR; DNA FRAGMENT; FLUORESCEIN ISOTHIOCYANATE; FLUORESCEIN ISOTHIOCYANATE VALYLALANYLASPARTYL FLUOROMETHYL KETONE; GENOMIC DNA; UNCLASSIFIED DRUG;

AGAR GEL ELECTROPHORESIS; APOPTOSIS; ARTICLE; CELL CULTURE; CELL LABELING; CELL MEMBRANE PERMEABILITY; CELL STRAIN MCF 7; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME ACTIVITY; ENZYME ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

EID: 0346157242     PISSN: 15524922     EISSN: None     Source Type: Journal    
DOI: 10.1002/cyto.a.10094     Document Type: Article

References (34)

1. Kerr JF, Wyllie H, Currie AR. Apoptosis: a basic phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26: 239-257.
2. Nicholson DW. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ 1999;6:1028-1042.
3. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998;281:1305-1308.
4. Robertson JD, Enoksson M, Suomela M, Zhivotovsky, Orrenius S. Caspase-2 acts upstream of mitochondria to promote cytochrome c release during etoposide-induced apoptosis. J Biol Chem 2002;277: 29803-29809.
5. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaseli KJ, Debatin K-K, Krammer PJ, Peter ME. Two CD95 (APO-I/Fas) signaling pathways. EMBO J 1998;17:1675-1687.
6. Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Litwack G, Alnemri ES. Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activated multiple Ced-3/ICE-like cysteine proteases. Proc Natl Acad Sci USA 1996;92: 14486-14491.
7. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM. FLICE, a novel FADD-homologous 1CE/CDE-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996;85: 817-827.
8. Hirata H, Takshashi S, Kobayashi S, Yonehara S, Sawai H, Okazaki T, Yamamoto K, Sasada M. Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-mediated apoptosis. J Exp Med 1998;187:587-600.
9. Slee EA, Adrain C, Martin SJ. Executioner caspase-3, -6, and -7 perform distinct non-redundant roles during the demolition phase of apoptosis. J Biol Chem 2001;276:7320-7326.
10. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beider DR, Poirier G, Salvesen GS, Dixit VM. Yama/CPP32b a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly (ADP-ribose) polymerase. Cell 1995;85:801-809.
11. Janicke RU, Sprengat ML, Wati MR, Porter AG. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 1998;273:9357-9360.
12. Schlegel J, Peters I, Orrenius S, Thornberry NA, Yamin TT, Nicholson DW. CPP32/apopain is a key interleukin 1b converting enzyme-like protease involved in Fas-mediated apoptosis. J Biol Chem 1996;315: 21-24.
13. Hug H, Los M, Hirt W, Debatin KM. Rhodamine 110-linked amino acids and peptides as substrates to measure caspase activity upon apoptosis induction in intact cells. Biochemistry 1999;38:13906-13911.
14. Komoriya A, Packard BS, Brown MJ, Wu M-L, Henkart PH. Assessment of caspase activities in intact apoptotic thymocytes using cell-permeable fluorogenic caspase substrates. J Exp Med 2000;191:1819-1828.
15. Dolle RE, Hoyer D, Prasad CV, Schmidt SJ, Helaszek CT, Miller RE, Ator MA. 1 aspartate-based peptide alpha-(2,6-dichlorobenzoyl)oxy) methyl ketones as potent time-dependent inhibitors of interluekin-1beta-converting enzyme. J Med Chem 1994;37:563-564.
16. Thornberry NA, Peterson EP, Zhao JJ, Howard AD, Griffin PR, Chapman KT. Inactivation of interleukin-1 beta converting enzyme peptide (acyloxy) methyl ketones. Biochemistry 1994;33:3934-3940.
17. Jayaraman S, Castro M, O'Sullivan M, Bragdon MJ, Holtzman MJ. Resistance to Fas-mediated T cell apoptosis in asthma. J Immunol 1999;162:1717-1722.
18. Chow SC, Weis M, Kass GE, Holstrom TH, Erikson JE, Orrenius S. Involvement of multiple proteases during Fas-mediated apoptosis in T lymphocytes. FEBS Lett 1995;364:134-138.
19. Margolin N, Raybuck SA, Wilson KP, Chen W, Fox T, Gu Y, Livingston D. Substrate and inhibitor specificity of interleukin-1b-converting enzyme and related caspases. J Biol Chem 1997;272:7223-7228.
20. Garcia-Calvo M, Peterson EP, Leiting B, Ruel R, Nicholson DW, Thornberry NA. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J Biol Chem 1998;273:32608-32613.
21. Ekert PG, Silke J, Vaus DL. Caspase inhibitors. Cell Death Differ 1999;6:1081-1086.
22. Kamada S, Washida M, Haegawa J, Kusano Y, Funahashi Y, Tsujimoto Y. Involvement of caspase-4 (-like) protease in Fas-mediated apoptotic pathway. Oncogene 1997;15:285-290.
23. L inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of X-linked inhibitor of X-linked inhibitor-of-apoptosis protein. J Biol Chem 2002; 277:11345-11351.
24. Slee EA, Zhu H, Chow SC, MacFarlane M, Nicholson DW, Cohen GM. Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z. VAD-.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem J 1996;315:21-24.
25. Johnson VL, Ko SCW, Holmstrmn TH, Erikson JE, Chow SC. Effector caspases are dispensable for the early nuclear morphological changes during chemical-induced apoptosis. J Cell Sci 2000;113:2941-2953.
26. Martin SJ, Finucane DM, Amarante-Mendes GP, O'Brien GA, Green DR. Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity. J Biol Chem 1996;271:28753-28756.
27. Mack A, Furmann C, Hacker G. Detection of caspases-activation in intact lymphoid cells using standard caspases substrates and inhibitors. J Immunol Methods 2000;241:19-31.
28. Bender E, Smolewski P, Amstad P, Darzynkiewicz. Activation of caspases measured in situ by binding of fluorochrome-labeled inhibitors of caspases (FLICA): correlation with DNA fragmentation. Exptl Cell Res 2000;259:308-313.
29. Smolewski P, Bender E, Du L, Hsieh T-C, Wu JM, Phelps DJ, Darzynkiewicz Z. Detection of caspases activation by fluorochrome-labeled inhibitors: multiparameter analysis by laser scanning cytometry. Cytometry 2001;44:73-82.
30. Amstad PA, Yu G, Johnson GL, Lee BW, Dhawan S, Phelps DJ. Detection of caspase activation in situ by fluorochrome-labeled caspase inhibitors. Biotechniques 2001;31:608-616.
31. Smolewski P, Grabarek J, Halick HD, Darzynkiewicz Z. Assay of caspases activation in situ combined with probing plasma membrane integrity to detect three distinct stages of apoptosis. J Immunol Methods 2002;265:111-121.
32. Faleiro L, Kobayashi R, Fearnhead H, Iazebnik Y. Multiple species of CPP32 and Mch2 are the major active caspases present in apoptotic cells. EMBO J 1997;16:2271-2281.
33. Holtzman MJ, Green JM, Jayaraman S, Arch RH. Regulation of T cell apoptosis. Apoptosis 2000;5:459-471.
34. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-1462.